Back to search results

Observational Study: Weight Management in Cardiovascular Disease

This observational study is looking at how a special clinic for heart and metabolism (cardiometabolic clinic) helps obese adults with heart conditions. The study will track changes in your body weight, body mass index (BMI), and how fat is distributed in your body over 12 months. You may be able to join if you are 18 or older, have a BMI of 30 or higher, and have at least one of several heart conditions like atrial fibrillation (AF) or coronary artery disease (CAD). The study aims to understand the impact of this clinic on these measures. There are 60 participants planned for this study, but its current status is unclear.

Study design
This is an observational study involving 60 participants. It will track changes in your health over 12 months.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your weight, BMI, and fat distribution will be measured at the beginning of the study and again after 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06053645

The Weight of Cardiovascular Disease

Recruiting
Not specifiedAges 18+Observational
Mayo Clinic
~60 participants
Updated 2025-10-20 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent body weight loss
Measured over 12 months
+2 more outcomes measured

Conditions

Cardiovascular Diseases
Obesity

Explore related trials

Cardiovascular DisorderObesity

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Kyla Lara-Breitinger, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

Preventive/Vascular Research Team
[email protected]
(507) 538-7425
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

BMI ≥30 kg/m2
At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
Patients evaluated in the Cardiometabolic clinic
Willingness to complete questionnaires/surveys
Ability to complete monthly self-assessments at home

Exclusion

BMI \<30 kg/m2
Pregnancy or lactating women
Hemodynamically unstable CVD
Active malignancy
Autoimmune or systemic inflammatory diseases
Severe renal or hepatic failure
Being considered unsafe to participate as determined by the study physician
Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician
Patients with active psychosis, mania, or substance use disorders

What this trial measures

  • Percent body weight loss12 months

    Total percent body weight loss will be reported at 12 months based on the following formula: (Starting baseline weight minus current weight) / (starting baseline weight) x 100 equals % of body weight loss.

  • Change in Body Mass Index (BMI)Baseline, 12 months

    Body Mass Index (BMI) will be calculated using the standard formula from participants' height and weight. BMI = (Weight in Pounds / (Height in inches x Height in inches)) x 703

  • Change in visceral adiposity distributionBaseline, 12 months

    Change in visceral adiposity distribution measured using dual energy X-ray absorptiometry (DEXA).